Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigations.
Int J Cancer
; 153(2): 252-264, 2023 07 15.
Article
in En
| MEDLINE
| ID: mdl-36408912
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Precision Medicine
/
Immune Checkpoint Inhibitors
Type of study:
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Int J Cancer
Year:
2023
Type:
Article
Affiliation country:
Germany